Aurinia Pharmaceuticals Inc (AUPH)
8.83
+0.06
(+0.68%)
USD |
NASDAQ |
Nov 22, 13:33
Aurinia Pharmaceuticals Profit Margin (Quarterly): 21.17% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 21.17% |
| June 30, 2024 | 1.26% |
| March 31, 2024 | -21.37% |
| December 31, 2023 | -59.60% |
| September 30, 2023 | -24.67% |
| June 30, 2023 | -27.70% |
| March 31, 2023 | -76.16% |
| December 31, 2022 | -91.60% |
| September 30, 2022 | -16.12% |
| June 30, 2022 | -126.0% |
| March 31, 2022 | -174.0% |
| December 31, 2021 | -142.4% |
| September 30, 2021 | -342.6% |
| June 30, 2021 | -710.1% |
| March 31, 2021 | -5.51K% |
| December 31, 2020 | -16.14% |
| September 30, 2020 | -145.3K% |
| June 30, 2020 | -91.53K% |
| March 31, 2020 | -86.44K% |
| December 31, 2019 | -141.4K% |
| September 30, 2019 | -8.28K% |
| June 30, 2019 | -54.83K% |
| March 31, 2019 | -41.43K% |
| December 31, 2018 | -12.25K% |
| September 30, 2018 | -4.89K% |
| Date | Value |
|---|---|
| June 30, 2018 | -54.16K% |
| March 31, 2018 | -51.59K% |
| December 31, 2017 | -11.11K% |
| September 30, 2017 | -45.24K% |
| June 30, 2017 | -729.2% |
| March 31, 2017 | -173.1K% |
| December 31, 2016 | -27.78K% |
| September 30, 2016 | -23.93K% |
| June 30, 2016 | -5.96K% |
| March 31, 2016 | -7.49K% |
| December 31, 2015 | -7.13K% |
| September 30, 2015 | -9.14K% |
| June 30, 2015 | -1.24K% |
| March 31, 2015 | -13.87K% |
| December 31, 2014 | -11.92K% |
| September 30, 2014 | |
| June 30, 2014 | -15.54K% |
| March 31, 2014 | -7.13K% |
| December 31, 2013 | -238.5% |
| September 30, 2013 | |
| June 30, 2013 | -1.14K% |
| March 31, 2013 | -893.2% |
| December 31, 2012 | -5.99K% |
| September 30, 2012 | -1.98K% |
| June 30, 2012 | -2.60K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-145.3K%
Minimum
Sep 2020
21.17%
Maximum
Sep 2024
-23.60K%
Average
-108.8%
Median
Profit Margin (Quarterly) Benchmarks
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -2.12K% |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |
| ImmunoPrecise Antibodies Ltd | -75.98% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -5.99% |
| Return on Assets | -4.19% |
| Return on Invested Capital | -5.99% |
| Gross Profit Margin (Quarterly) | 91.10% |
| Operating Margin (Quarterly) | 17.33% |
| Return on Net Operating Assets | -11.47% |